Common use of Development and Marketing Clause in Contracts

Development and Marketing. 3.1. In consideration of the rights granted to Memory under this Agreement, Memory shall use commercially reasonable efforts (i) to develop (through research, development, marketing and/or sublicensing activities, either alone or in collaboration with Third Parties) Finished [*] CONFIDENTIAL TREATMENT IS REQUESTED Products, and (ii) to register and market (either alone and/or in collaboration with Third Parties) Finished Products in the United States, Japan and in four countries of the European Union which Memory shall select from the group consisting of Germany, France, United Kingdom, Italy and Spain. 3.2. Neither Bayer nor a Bayer Affiliate shall have any obligation to provide Memory, a Memory Affiliate and/or a Sublicensee with any service or assistance as to (i) the non-clinical and clinical development of Compound and Finished Products, and (ii) the registration and marketing of Finished Products. Memory is solely responsible, and is hereby authorized by Bayer to contact a Third Party contractor in order to establish an ongoing supply of Compound which Memory needs for the non-clinical and clinical development of Finished Products as well as for marketing purposes. Bayer does not have any obligation to supply Memory with Compound.

Appears in 1 contract

Sources: License Agreement (Memory Pharmaceuticals Corp)

Development and Marketing. [*] CONFIDENTIAL TREATMENT IS REQUESTED 3.1. In consideration of the rights granted to Memory under this Agreement, Memory shall use commercially reasonable efforts (i) to develop (through research, development, marketing and/or sublicensing activities, either alone or in collaboration with Third Parties) Finished [*] CONFIDENTIAL TREATMENT IS REQUESTED Products, and (ii) to register and market (either alone and/or in collaboration with Third Parties) Finished Products in the United States, Japan and in four countries of the European Union which Memory shall select from the group consisting of Germany, France, United Kingdom, Italy and Spain. 3.2. Neither Bayer nor a Bayer Affiliate shall have any obligation to provide Memory, a Memory Affiliate and/or a Sublicensee with any service or assistance as to (i) the non-clinical and clinical development of Compound and Finished Products, and (ii) the registration and marketing of Finished Products. Memory is solely responsible, and is hereby authorized by Bayer to contact a Third Party contractor in order to establish an ongoing supply of Compound which Memory needs for the non-clinical and clinical development of Finished Products as well as for marketing purposes. Bayer does not have any obligation to supply Memory with Compound.

Appears in 1 contract

Sources: License Agreement (Memory Pharmaceuticals Corp)